Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Ocugen, Inc (OCGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Ocugen's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.670 -0.100    -3.61%
17/08 - Closed. Currency in USD ( Disclaimer )
Pre Market
2.670
-0.000
-0.000%
6:06:59 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 3,973,267
  • Bid/Ask: 2.640 / 2.830
  • Day's Range: 2.670 - 2.770
Ocugen 2.670 -0.100 -3.61%
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
31/03
2021
31/12
2021
30/09
2021
30/06
Total Revenue - - - -
Revenue - - - -
Other Revenue, Total - - - -
Cost of Revenue, Total - - - -
Gross Profit - - - -
Total Operating Expenses 18.03 14.57 10.39 25.61
Selling/General/Admin. Expenses, Total 10.12 7.47 4.51 6.76
Research & Development 7.92 7.1 6.28 18.85
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) - - -0.4 -
Other Operating Expenses, Total - - - -
Operating Income -18.03 -14.57 -10.39 -25.61
Interest Income (Expense), Net Non-Operating - -0.04 -0.01 -0.01
Gain (Loss) on Sale of Assets - - - -
Other, Net 0.01 0.03 -0.4 -0.33
Net Income Before Taxes -18.02 -14.58 -10.81 -25.95
Provision for Income Taxes - - -0.05 -
Net Income After Taxes -18.02 -14.58 -10.76 -25.95
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -18.02 -14.58 -10.76 -25.95
Total Extraordinary Items - - - -
Net Income -18.02 -14.58 -10.76 -25.95
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -18.02 -14.58 -10.76 -25.95
Dilution Adjustment - - - -
Diluted Net Income -18.02 -14.58 -10.76 -25.95
Diluted Weighted Average Shares 205.69 199.25 198.79 195.57
Diluted EPS Excluding Extraordinary Items -0.09 -0.07 -0.05 -0.13
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0.09 -0.07 -0.06 -0.13
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OCGN Comments

Write your thoughts about Ocugen, Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Kevin De Meester
Kevin De Meester Jul 08, 2022 10:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
There’s still hope for ocugen
Paco Bv
Pacob May 23, 2022 6:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MALVERN, Pa., May 23, 2022 -- Ocugen, Inc., a biotechnology company focused on discovering, developing, and commercializing novel gene therapies, biologicals, and vaccines, today announced that the U.S. Food and Drug Administration (FDA) lifted the clinical hold on the Company’s Phase 2/3 clinical trial, OCU-002, for COVAXIN™ (BBV152). 'We’re extremely pleased..'
Paco Bv
Pacob Apr 25, 2022 12:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
April 25, 2022 7:33 AM EDT ~ Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial
Paco Bv
Pacob Apr 18, 2022 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
April 18, 2022 7:11 AM EDT ~ Ocugen, Inc. to Commercialize COVAXIN™ in Mexico, Rights Now Encompassing All of North America
Trader Trader
Trader Trader Apr 18, 2022 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol. Pacob, you must be losing money holding this to keep typing irrelevant information just to make yourself happy.
Paco Bv
Pacob Apr 18, 2022 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
one thing is true, that news made me happy
Trader Trader
Trader Trader Apr 18, 2022 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Pacob, covid is almost over in USA and Ocugen can only make money selling covaxin in USA. Furthermore, OCGN still has not submited an application to FDA, I believe. I am surprised stock price is still this high.
Paco Bv
Pacob Apr 18, 2022 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
new variant landed in Europe, time to take a deep breath, to savor this brief moment of freedom, soon you will miss it deeply
Trader Trader
Trader Trader Apr 18, 2022 9:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lol You must live in a cave and believe all this. Do you live in USA?
Paco Bv
Pacob Apr 01, 2022 9:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
April 1, 2022 7:37 AM EDT ~ Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration
Kevin De Meester
Kevin De Meester Mar 17, 2022 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally some green
Gandhi Mahatma
Gandhi Mahatma Mar 17, 2022 10:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Back above my average 😎
NAGARAJAN MUNUSAMY
NAGARAJAN MUNUSAMY Mar 04, 2022 8:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tesla...😎😎😎
NAGARAJAN MUNUSAMY
NAGARAJAN MUNUSAMY Mar 04, 2022 8:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ocugen, $OCGN, request for pediatric use of COVID-19 vaccine rejected by FDA.
Trader Trader
Trader Trader Mar 04, 2022 8:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
more like Yugo.
Vlas Dacian
Vlas Dacian Mar 04, 2022 7:22AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1.5$
NAGARAJAN MUNUSAMY
NAGARAJAN MUNUSAMY Mar 03, 2022 10:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
no revenue🤣🤣🤣
Gandhi Mahatma
Gandhi Mahatma Mar 03, 2022 10:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You are literally all over the place with this stock. Are u bullish or bearish? Make up your mind ffs
Ole Rii
Ole Rii Mar 03, 2022 10:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ahahahahahaha
Gábor Simon
Gábor Simon Mar 03, 2022 10:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What a recognition. Has it ever been at all?
Paco Bv
Pacob Feb 24, 2022 2:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
COVAXIN is the safest for children, has a good balance between safety and efficacy, also more persistent than some of the best. Not enough for u? Here : 'when combining shots of vaccines with different technology, immunity is stronger'
Trader Trader
Trader Trader Feb 24, 2022 2:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
blah blah blah. vaccine no one uses in USA and you keep going blah blah
Trader Trader
Trader Trader Feb 24, 2022 2:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
children do NOT need to get vaccinated. science clearly shows that.
Trader Trader
Trader Trader Feb 24, 2022 2:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
children do NOT need to get vaccinated
Paco Bv
Pacob Feb 24, 2022 2:50PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they r very contagious, children touch everything and they infect the whole family, they cause many job aussences, it goes against business productivity
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email